Literature DB >> 16413227

STAT4/6-dependent differential regulation of chemokine receptors.

Soon Ha Kim1, Kurt V Gunst, N Sarvetnick.   

Abstract

The major cell fate decision of the CD4+ helper T cells is the development of Th1 and Th2 phenotype, the balance of which determines the outcome of a wide variety of autoimmune responses. Signal transducers and activators of transcription (STATs), in particular STAT4 and STAT6, are essential for the development of Th1 and Th2 cells, respectively. We used Balb/c mice lacking STAT4 or STAT6 to explore the ability of helper T cells to express chemokine receptors. We demonstrated that both STAT4-/- and STAT6-/- CD4+ lymphocytes showed impaired expansion as well as differentiation into IFN-gamma-secreting Th1 cells and IL2-, IL4-, IL10-secreting Th2 cells. Interestingly, the expression of chemokine receptors, which is STAT4/6-dependent, was differentially regulated via two distinct mechanisms, positively (CCR3, CCR4) and negatively (CCR5, CCR7). These results provide the basis for STAT-dependent differential regulation of chemokine receptors in Th subsets.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16413227     DOI: 10.1016/j.clim.2003.10.002

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  9 in total

Review 1.  The integrative roles of chemokines at the maternal-fetal interface in early pregnancy.

Authors:  Mei-Rong Du; Song-Cun Wang; Da-Jin Li
Journal:  Cell Mol Immunol       Date:  2014-08-11       Impact factor: 11.530

2.  STAT4 contributes to adipose tissue inflammation and atherosclerosis.

Authors:  A D Dobrian; M A Hatcher; J J Brotman; E V Galkina; P Taghavie-Moghadam; H Pei; B A Haynes; J L Nadler
Journal:  J Endocrinol       Date:  2015-08-18       Impact factor: 4.286

3.  The CXCL12/CXCR4 axis is involved in the maintenance of Th2 bias at the maternal/fetal interface in early human pregnancy.

Authors:  Hai-Lan Piao; Yu Tao; Rui Zhu; Song-Cun Wang; Chuan-Ling Tang; Qiang Fu; Mei-Rong Du; Da-Jin Li
Journal:  Cell Mol Immunol       Date:  2012-08-13       Impact factor: 11.530

4.  SOCS1 regulates CCR7 expression and migration of CD4+ T cells into peripheral tissues.

Authors:  Cheng-Rong Yu; Rashid M Mahdi; Xuebin Liu; Allen Zhang; Tetsuji Naka; Tadamitsu Kishimoto; Charles E Egwuagu
Journal:  J Immunol       Date:  2008-07-15       Impact factor: 5.422

5.  Unexpected impairment of TNF-α-induced maturation of human dendritic cells in vitro by IL-4.

Authors:  Valérie Chabot; Laurence Martin; Daniel Meley; Luc Sensebé; Christophe Baron; Yvon Lebranchu; Frédéric Dehaut; Florence Velge-Roussel
Journal:  J Transl Med       Date:  2016-04-14       Impact factor: 5.531

6.  Complement Activation and STAT4 Expression Are Associated with Early Inflammation in Diabetic Wounds.

Authors:  Kenji M Cunnion; Neel K Krishna; Haree K Pallera; Angela Pineros-Fernandez; Magdielis Gregory Rivera; Pamela S Hair; Brittany P Lassiter; Ryan Huyck; Mary A Clements; Antoinette F Hood; George T Rodeheaver; Patrick S Cottler; Jerry L Nadler; Anca D Dobrian
Journal:  PLoS One       Date:  2017-01-20       Impact factor: 3.240

Review 7.  Of Lymph Nodes and CLL Cells: Deciphering the Role of CCR7 in the Pathogenesis of CLL and Understanding Its Potential as Therapeutic Target.

Authors:  Carlos Cuesta-Mateos; Jennifer R Brown; Fernando Terrón; Cecilia Muñoz-Calleja
Journal:  Front Immunol       Date:  2021-03-24       Impact factor: 7.561

8.  IL-27 receptor signaling regulates CD4+ T cell chemotactic responses during infection.

Authors:  Emily Gwyer Findlay; Ana Villegas-Mendez; J Brian de Souza; Colette A Inkson; Tovah N Shaw; Christiaan J Saris; Christopher A Hunter; Eleanor M Riley; Kevin N Couper
Journal:  J Immunol       Date:  2013-03-27       Impact factor: 5.422

9.  STAT4 deficiency reduces obesity-induced insulin resistance and adipose tissue inflammation.

Authors:  Anca D Dobrian; Elena V Galkina; Qian Ma; Margaret Hatcher; Sabai Myo Aye; Mathew J Butcher; Kaiwen Ma; Bronson A Haynes; Mark H Kaplan; Jerry L Nadler
Journal:  Diabetes       Date:  2013-08-12       Impact factor: 9.461

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.